Overactive Bladder - Results from #1920

Preparation, characterization and pharmacological evaluation of tolterodine hydrogels for the treatment of overactive bladder - Abstract August 19, 2013

Cost-effectiveness analysis of solifenacin versus oxybutynin immediate-release in the treatment of patients with overactive bladder in the United Kingdom - Abstract August 16, 2013

Sacral neuromodulation in patients with idiopathic overactive bladder after initial botulinum toxin therapy - Abstract August 15, 2013

Management of OAB in those over age 65 - Abstract August 14, 2013

New therapies in the treatment of overactive bladder - Abstract August 13, 2013

Persistence with first line anticholinergic medication in treatment-naïve overactive bladder patients - Abstract August 9, 2013

The association between the self-perception period of overactive bladder symptoms and overactive bladder symptom scores in a non-treated population and related sociodemographic and lifestyle factors - Abstract August 8, 2013

Dysfunctional elimination syndromes-How closely linked are constipation and encopresis with specific lower urinary tract conditions? - Abstract August 7, 2013

Men with type 2 diabetes and erectile dysfunction are a particular risk group for LUTS - Results of the Witten Diabetes Survey - Abstract August 6, 2013

Increased bladder wall thickness in diabetic and nondiabetic women with overactive bladder - Abstract August 2, 2013

Oestrogens and overactive bladder - Abstract August 1, 2013

Effect of low-dose triple therapy using gabapentin, amitriptyline, and a nonsteroidal anti-inflammatory drug for overactive bladder symptoms in patients with bladder pain syndrome - Abstract August 1, 2013

Neurogenic detrusor overactivity is associated with decreased expression and function of the large conductance voltage- and ca(2+)-activated k(+) channels - Abstract August 1, 2013

Percutaneous tibial nerve stimulation for the long-term treatment of overactive bladder: 3-year results of the STEP study - Abstract July 31, 2013

Male overactive bladder: Pharmacotherapy for the male - Abstract July 29, 2013

Treatment status and progression or regression of lower urinary tract symptoms among adults in a general population sample - Abstract July 26, 2013

Evidence available on the use of the selective β3-adrenoceptor agonist mirabegron for the treatment of overactive bladder - Abstract July 25, 2013

A retrospective study on female urological surgeries over the 10 years following spinal cord lesion - Abstract July 24, 2013

Efficacy of fesoterodine compared with extended-release tolterodine in men and women with overactive bladder - Abstract July 23, 2013

Imidafenacin on bladder and cognitive function in neurologic OAB patients - Abstract July 22, 2013

Page 97 of 125